RGD peptide‐modified phase‐change nanoparticles combining with low‐intensity focused ultrasound for targeting and imaging experiments of gastric cancer in vivo and vitro
10.3760/cma.j.issn.1004-4477.2019.02.018
- VernacularTitle:RGD 肽修饰的相变型纳米粒联合低强度聚焦超声对胃癌的体内外寻靶及显像研究
- Author:
Zhangluxi LIU
1
;
Yaxu WANG
;
Lan HAO
;
Shiji ZHOU
Author Information
1. 重庆医科大学第二附属医院胃肠外科
- Keywords:
Contrast‐enhanced ultrasound;
Gastric cancer;
Nnanoparticle;
Phase change;
Poly ( lactic‐co‐glycolic acid)
- From:
Chinese Journal of Ultrasonography
2019;28(2):174-180
- CountryChina
- Language:Chinese
-
Abstract:
To prepare RGD peptide modified perfluorohexane ( PFH ) polymer nanoparticles RGD‐PFH‐NPs and investigate its basic characteristics ,targeting ability and combine with low‐intensity focused ultrasound ( LIFU ) for ultrasonic imaging in vivo and vitro . Methods Targeted nanoparticles RGD‐PFH‐NPs were prepared by double emulsifying method and carbodiimide method . T heir morphology and distribution were observed . T he particle size ,zeta potential and connection probability were measured . T he phase‐changed properties and the LIFU‐induced imaging ability in contrast‐enhanced ultrasound mode of RGD‐PFH‐NPs were investigated in vivo and vitro . T he tagetability of nanoparticles to human gastric cancer cell line M GC803 and tumor‐bearing nude mouse were observed through targeting group and non‐targeting group . Results T he prepared sample was milky w hite suspension liquid . T he RGD‐PFH‐NPs were spherical uniform size ,good dispersion w hen observed through the optical microscope and transmission electron microscopy . T he particle size was ( 259 .3 ± 42 .6) nm and the Zeta potential was ( －17 .6+5 .4) mV . T he connection probability of RGD peptide was 89 .13% . With 70℃ water bath and LIFU stimulation RGD‐PFH‐NPs can remarkably change phase and show good imaging performance in both conventional ultrasound and contrast‐enhanced ultrasound mode in vivo and vitro . The connection probability to M GC803 cells in targeting group ( RGD‐PFH‐NPs ) and the non‐targeting group( PFH‐NPs) were 82 .59% and 2 .96% . T he accumulation of nanoparticles in the RGD‐PFH‐NPs group in tumor tissues was significantly higher than that in the non‐targeted PFH‐NPs group( P) . Conclusions The constructed nanoparticles RGD‐PFH‐NPs ,providing contrast‐enhanced ultrasonic imaging and excellent targeting ability to human gastric cancer cells M GC803 and gastric cancer tissue ,is expected to become a new type of gastric cancer targeted ultrasound contrast agent .
